135 related articles for article (PubMed ID: 7604948)
1. The anti-inflammatory profile of fluticasone propionate.
Johnson M
Allergy; 1995; 50(23 Suppl):11-4. PubMed ID: 7604948
[TBL] [Abstract][Full Text] [Related]
2. Development of fluticasone propionate and comparison with other inhaled corticosteroids.
Johnson M
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S434-9. PubMed ID: 9563368
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate--an update on preclinical and clinical experience.
Fuller R; Johnson M; Bye A
Respir Med; 1995 Sep; 89 Suppl A():3-18. PubMed ID: 7569173
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.
Hagan JB; Kita H; Gleich GJ
Clin Exp Allergy; 1998 Aug; 28(8):999-1006. PubMed ID: 9756205
[TBL] [Abstract][Full Text] [Related]
5. Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis.
Zhang X; Moilanen E; Kankaanranta H
Eur J Pharmacol; 2001 Nov; 431(3):365-71. PubMed ID: 11730731
[TBL] [Abstract][Full Text] [Related]
6. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor.
Högger P; Rohdewald P
Steroids; 1994 Oct; 59(10):597-602. PubMed ID: 7878687
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling.
Silvestri M; Sabatini F; Scarso L; Cordone A; Dasic G; Rossi GA
Int Arch Allergy Immunol; 2002 May; 128(1):51-8. PubMed ID: 12037401
[TBL] [Abstract][Full Text] [Related]
8. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
Powell N; Till SJ; Kay AB; Corrigan CJ
Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone.
Zhang X; Moilanen E; Kankaanranta H
Eur J Pharmacol; 2000 Oct; 406(3):325-32. PubMed ID: 11040338
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate for asthma prophylaxis.
Drug Ther Bull; 1994 Apr; 32(4):25-7. PubMed ID: 7635021
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB
Eur Respir J; 1996 Oct; 9(10):2077-86. PubMed ID: 8902470
[TBL] [Abstract][Full Text] [Related]
13. RPR 106541, a novel, airways-selective glucocorticoid: effects against antigen-induced CD4+ T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung.
Underwood SL; Raeburn D; Lawrence C; Foster M; Webber S; Karlsson JA
Br J Pharmacol; 1997 Oct; 122(3):439-46. PubMed ID: 9351499
[TBL] [Abstract][Full Text] [Related]
14. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
van As A; Bronsky EA; Dockhorn RJ; Grossman J; Lumry W; Meltzer EO; Seltzer JM; Rogenes PR
J Allergy Clin Immunol; 1993 Jun; 91(6):1146-54. PubMed ID: 8509578
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GM-CSF secretion by topical corticosteroids and nedocromil sodium. A comparison study using nasal polyp epithelial cells.
Mullol J; Roca-Ferrer J; Xaubet A; Raserra J; Picado C
Respir Med; 2000 May; 94(5):428-31. PubMed ID: 10868704
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages.
Ek A; Larsson K; Siljerud S; Palmberg L
Allergy; 1999 Jul; 54(7):691-9. PubMed ID: 10442524
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion.
Roca-Ferrer J; Mullol J; Lopez E; Xaubet A; Pujols L; Fernández JC; Picado C
Eur Respir J; 1997 Jul; 10(7):1489-95. PubMed ID: 9230235
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease.
Salter M; Biggadike K; Matthews JL; West MR; Haase MV; Farrow SN; Uings IJ; Gray DW
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L660-7. PubMed ID: 17575011
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the constitutive or cytokine-induced bronchial epithelial cell functions in vitro by fluticasone propionate.
Sabatini F; Silvestri M; Sale R; Serpero L; Raynal ME; Di Blasi P; Rossi GA
Immunol Lett; 2003 Oct; 89(2-3):215-24. PubMed ID: 14556981
[TBL] [Abstract][Full Text] [Related]
20. Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo.
Petersen H; Kullberg A; Edsbäcker S; Greiff L
Br J Clin Pharmacol; 2001 Feb; 51(2):159-63. PubMed ID: 11259988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
